President Donald Trump has called on major health and tech companies to support the development of artificial intelligence, emphasizing that AI is not a ‘cartel’ that stifles competition. His remarks came as the Coalition for Health AI, an organization comprising leading industry figures, announced its initiative to evaluate AI tools that currently lack regulatory oversight. The coalition is spearheaded by prominent companies in both healthcare and technology sectors, including names like Alphabet, IBM, and healthcare providers such as Cleveland Clinic and Mayo Clinic.
The initiative aims to ensure that AI technologies in healthcare and other domains are developed responsibly while fostering innovation and competition. Participants in the coalition are working to establish guidelines for AI use, focusing on transparency, safety, and ethical considerations. Trump’s message was framed as a call to action for the private sector to lead in AI development rather than being constrained by regulatory barriers. This is part of a broader effort to position the United States as a global leader in technological innovation and healthcare advancements.
Industry leaders have expressed support for the initiative, though some have raised concerns about the potential for over-regulation. The coalition is expected to release its findings and recommendations in the coming months, which could influence future policy decisions and regulatory frameworks for AI. As AI continues to reshape industries, the coalition’s efforts highlight the growing importance of balancing innovation with ethical and regulatory responsibilities.